GlaxoSmithKline ( (GB:GSK) ) has provided an update.
GSK has published its Annual Report for the year ending December 31, 2024, which is now available on the company’s website and has been submitted to the UK’s Financial Conduct Authority’s National Storage Mechanism for inspection. The report complies with the FCA’s disclosure requirements, and shareholders who opted for paper communications will receive a hard copy along with the Notice of Annual General Meeting 2025 around March 24, 2025.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a global healthcare company operating in the pharmaceutical industry, focusing on the development and manufacturing of medicines, vaccines, and consumer healthcare products.
YTD Price Performance: 10.18%
Average Trading Volume: 7,653,673
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £59.85B
Learn more about GSK stock on TipRanks’ Stock Analysis page.